The BCG vaccine is administered via an intradermal injection. The typical site for the injection is the outer aspect of the upper arm. In most cases, the vaccine is given shortly after birth or during early childhood, particularly in countries with high rates of tuberculosis. In some regions, particularly in countries where TB rates are lower, the BCG vaccine may not be routinely administered unless there is a specific risk.

The BCG vaccine is sometimes administered in adults as part of the treatment of bladder cancer. The administration is done directly into the bladder through a catheter, which stimulates an immune response against the cancerous cells. This is considered to be an off-label use, and treatment is always conducted under medical supervision.

The BCG vaccine works through stimulating the body’s immune system to recognize and fight the bacteria that cause tuberculosis. Upon injection, the weakened Mycobacterium bovis bacteria in the vaccine trigger an immune response. This includes the activation of T-cells, which play a central role in recognizing and destroying infected cells, as well as the production of antibodies that help the body identify and neutralize the TB bacteria if exposed in the future.

It teaches the immune system to recognize the components of these bacteria without developing the full disease. If later exposed to Mycobacterium tuberculosis-the causative agent, his immune system would better place the defense, hence much lesser chances of getting actively developed TB. The produced immunological memory may persist during a few years; still, the level of protection due to age and the type may differ.

BCG vaccination is relatively safe and should result in very few major reaction, although some side effects should be anticipated. Side effects usually include:

Injection Site Reactions: The most common side effect is a small, localized reaction at the injection site, such as redness, swelling, or mild pain. Within a few weeks, a small ulcer or blister can form at the injection site, which usually heals, leaving a scar.

Fever: Some people can develop a mild fever following vaccination.

Lymphadenitis: Less commonly, the vaccine may also cause lymph node inflammation- usually in the armpit or near the vaccination site.

Systemic Reactions: Rarely, stronger reactions such as allergic responses or generalized skin rashes can occur. These are not to be treated by laymen.

Bacillus Calmette-Guérin Infection: In rarest of cases, the BCG infection can become active in any person with a compromised defense mechanism.

There are people who should not receive or cautiously take the BCG vaccine. These include:

Immunocompromised Individuals: They include individuals suffering from HIV/AIDS, cancer, and anyone on immunosuppressive drugs. The BCG vaccine should not be taken by immunocompromised individuals since these people are at high risk of an unfavorable effect, which might even result in a live infection.

Pregnancy: No vaccination for pregnant women is suggested. The vaccine does not show clear effects on the fetus; however, live vaccines are avoided during pregnancy unless absolutely essential. 

Exposure to Tuberculosis: Patients who are already infected with TB should not be vaccinated because vaccination is not meant for active cases.

Infants and Children: The vaccine is generally safe for infants and children, but it should be avoided in the case of severe allergies to any component of the vaccine.

1. Immunosuppressive Medications: Using the BCG vaccine with immunosuppressive drugs (such as corticosteroids or chemotherapy) may impair the immune response to the vaccine, reducing its effectiveness and increasing the risk of infections. Close monitoring is necessary if these medications are being used concurrently.
2. Live Vaccines: The BCG vaccine is a live vaccine, and it should not be administered simultaneously with other live vaccines (like measles or varicella). This could increase the risk of adverse reactions or reduce the effectiveness of either vaccine. A waiting period between the use of live vaccines is recommended.
3. Antibiotics: Certain antibiotics, particularly those that affect immune responses, might interfere with the effectiveness of the BCG vaccine. For example, antibiotics like rifampin may alter the body’s ability to mount an immune response to the vaccine. Consultation with a healthcare provider is essential to determine the best course of action.
4. HIV and Immunocompromised Individuals: The BCG vaccine is generally avoided in individuals with HIV or other immune system deficiencies, as it could increase the risk of infection due to the live bacteria in the vaccine. Special precautions and alternative treatments should be considered for these patients.

The BCG vaccine is usually administered as a single dose. The specific dosage and administration schedule may depend on the country, the individual’s health status, and the specific guidelines issued by public health authorities.

Routine Childhood Vaccination: In countries where TB is endemic, the BCG vaccine is administered as part of routine childhood vaccination. This is usually done within the first few days or weeks of life.

Bladder Cancer Treatment: The BCG vaccine is given intravesically via a catheter in bladder cancer treatment. The number of doses and the frequency of treatment depend on the patient’s condition and the specific protocol of the cancer treatment.

In most cases, the BCG vaccine is administered as part of public health vaccination programs and does not require a prescription. However, for special indications, such as bladder cancer treatment, the vaccine must be prescribed and administered by a healthcare professional. In countries where the vaccine is not routinely given as part of childhood immunization programs, a prescription may be necessary.

1. What is the BCG vaccine?

   • The BCG (Bacillus Calmette-Guérin) vaccine is a live attenuated vaccine derived from a strain of Mycobacterium bovis used primarily to prevent tuberculosis.

2. How does the BCG vaccine work?

   • The BCG vaccine works by stimulating the immune system to recognize and fight Mycobacterium tuberculosis, thereby providing protection against TB infection.

3. Who should receive the BCG vaccine?

   • It is generally recommended for infants, particularly in countries with high rates of tuberculosis, as well as for certain high-risk groups, including healthcare workers.

4. In which countries is the BCG vaccine commonly given?

   • The BCG vaccine is primarily administered in countries with a high prevalence of tuberculosis, including many parts of Africa, Asia, and Eastern Europe.

5. What are the common side effects of the BCG vaccine?

   • Common side effects include mild fever, local inflammation or ulceration at the injection site, and swollen lymph nodes. Serious side effects are rare.

6. Is the BCG vaccine effective in preventing tuberculosis?

   • The BCG vaccine provides moderate protection against severe forms of TB in children, such as TB meningitis and disseminated TB, but its effectiveness against pulmonary TB in adults is variable.

7. Can the BCG vaccine be used to treat bladder cancer?

   • Yes, the BCG vaccine is used intravesically to treat superficial bladder cancer by stimulating the immune response against cancer cells.

8. How is the BCG vaccine administered?

   • The BCG vaccine is administered via subcutaneous injection, usually in the upper arm for children, or through intravesical instillation for bladder cancer.

9. What is the recommended schedule for the BCG vaccine?

   • For infants, the BCG vaccine is typically given at birth or within the first year, while the bladder cancer treatment involves weekly instillations over several weeks.

10. Are there any contraindications for the BCG vaccine?

    • The BCG vaccine should not be given to individuals with immunosuppression, those with a known allergy to BCG, or individuals with active TB infection.

11. Can someone who has had the BCG vaccine develop tuberculosis?

    • Yes, while the BCG vaccine reduces the risk of severe forms of TB, it does not guarantee complete protection, and vaccinated individuals can still contract TB.

12. Can the BCG vaccine cause a positive TB skin test?

    • Yes, the BCG vaccine can result in a positive reaction to the tuberculin skin test (TST), which can complicate TB diagnosis.

13. How long does immunity from the BCG vaccine last?

    • The duration of immunity from the BCG vaccine varies, but it generally lasts for at least 10 years, with ongoing surveillance recommended in high-risk areas.

14. Is the BCG vaccine safe during pregnancy?

    • The BCG vaccine is not routinely recommended during pregnancy, but if the benefits outweigh the risks for high-risk individuals, it may be considered.

15. What happens if a child does not receive the BCG vaccine?

    • If a child does not receive the BCG vaccine, they may be at higher risk for certain forms of tuberculosis, particularly in areas where TB is prevalent.

16. How does the BCG vaccine relate to COVID-19?

    • Some studies have explored whether the BCG vaccine may provide non-specific immune benefits against respiratory viruses like COVID-19, but more research is needed to establish any protective effects.

17. What should be reported to a healthcare provider after receiving the BCG vaccine?

    • Parents and patients should report any unusual or severe reactions to the injection site, persistent fever, or signs of systemic infection to a healthcare provider.

18. Are there any alternative vaccines for tuberculosis?

    • Currently, BCG remains the primary vaccine for TB prevention in many countries; however, research is ongoing regarding new vaccines that may offer better protection.

19. How can someone access the BCG vaccine?

    • The BCG vaccine is provided through public health programs and may be available at hospitals, clinics, or specialized vaccination centers, especially in high-incidence areas.

20. What should be done if the BCG vaccine is administered incorrectly?

    • If the BCG vaccine is administered improperly or someone has concerns, it is recommended to contact a healthcare provider for further assessment and potential follow-up.